CBT-I vs. MBTI for TBI-Related Insomnia
Trial Summary
What is the purpose of this trial?
This study is a prospective two-arm, single blind randomized controlled trial design to compare the clinical effectiveness of telemedicine-delivered, 6-session, standardized cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) in treating insomnia symptoms and ameliorating depressive symptoms in persons with mild to moderate TBI and comorbid Post-Traumatic Stress Symptoms (PTSS) and insomnia symptoms in a 360 patients. Participants will undergo assessment (psychosocial questionnaires, neurocognitive testing, sleep monitoring) at baseline, at the end of treatment, and at 2-, 6- and 12-weeks post-treatment. The primary outcome is sleep as measured by the Insomnia Severity Index (ISI).
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications, but if you are using psychotropic medications, you need to be on a stable dosage for at least three weeks before the study.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I) and Mindfulness-Based Treatment for Insomnia (MBTI) for TBI-related insomnia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I) is commonly used to improve sleep outcomes in individuals with traumatic brain injury (TBI). Mindfulness-Based Treatments for Insomnia (MBTI) have been found to improve sleep and reduce cognitive arousal, which are important for managing insomnia.12345
Is CBT-I and MBTI safe for treating insomnia?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is considered a safe and effective non-drug treatment for insomnia, with strong support from health organizations. Mindfulness-Based Therapy for Insomnia (MBTI) is also being explored as a safe alternative, especially for older adults, though more research is needed to fully understand its safety profile.23467
How does the treatment CBT-I vs. MBTI for TBI-related insomnia differ from other treatments?
CBT-I (Cognitive Behavioral Therapy for Insomnia) and MBTI (Mindfulness-Based Treatment for Insomnia) are unique because they focus on changing sleep-related thoughts and behaviors and incorporating mindfulness to reduce stress, rather than using medication. These therapies are particularly promising for individuals with traumatic brain injury (TBI) as they not only address insomnia but may also help with related issues like mood, pain, and cognitive function.128910
Research Team
Luis Buenaver, PhD
Principal Investigator
Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for adults over 18 with mild to moderate traumatic brain injury (TBI) who have insomnia and post-traumatic stress symptoms. They must have had the TBI for at least 3 weeks, show signs of insomnia, be able to give informed consent, and use a computer.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CBT-I or MBTI treatment over 6 sessions delivered via telemedicine
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2-, 6-, and 12-weeks post-treatment
Treatment Details
Interventions
- Cognitive behavioral therapy for insomnia (CBT-I) (Behavioural Intervention)
- Mindfulness-based treatment for insomnia (MBTI) (Behavioural Intervention)
Cognitive behavioral therapy for insomnia (CBT-I) is already approved in Canada for the following indications:
- Insomnia disorder
- Major depressive disorder with comorbid insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Department of Defense Congressionally Directed Medical Research Program
Collaborator